## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 3.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($554.78)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. SDA Awards $1.6 Billion in Tranche 3 Tracking Layer Contracts to Rocket Lab and Northrop Grumman**
- Source: SatNews Publishers | 20251228T151744 | Bullish | Relevance: 100%
- The Space Development Agency (SDA) has awarded $1.6 billion in contracts to Rocket Lab and Northrop Grumman for the Tranche 3 Tracking Layer of the Proliferated Warfighter Space Architecture. These contracts will fund the construction and operation of 36 satellites to enhance the Pentagon's ability to detect and track advanced missile threats. Rocket Lab will receive $805 million for 18 satellites, marking its largest contract, while Northrop Grumman will receive $764 million for 18 satellites, adding to its extensive involvement in the PWSA.

**2. RTX Secures $104M ESSM Deal, Strengthens Global Missile Leadership**
- Source: The Globe and Mail | 20251229T140900 | Somewhat-Bullish | Relevance: 72%
- RTX Corporation's Raytheon segment secured a $104.1 million contract for technical and design agent engineering support for the Evolved SeaSparrow Missile (ESSM) and NATO SeaSparrow Missile Systems programs, with work set to complete by December 31, 2026. This deal, combining purchases for the U.S. Navy and other countries, underscores the global demand for RTX's combat-proven ESSM missile, a defense solution against high-speed anti-ship cruise missiles and other threats. The missile and missile defense systems market is projected to grow, benefiting RTX and other defense contractors like Northrop Grumman, Lockheed Martin, and Boeing.

**3. TXT to Supply Aerosonde VTOL UAS to Tantita Security Services**
- Source: The Globe and Mail | 20251230T144432 | Somewhat-Bullish | Relevance: 63%
- Textron Inc.'s subsidiary, Textron Systems Corporation, has secured a contract to supply its Aerosonde vertical takeoff and landing (VTOL) unmanned aircraft system (UAS) to Tantita Security Services. This deal, involving three Aerosonde Mk. 4.7 VTOL UAS, aims to enhance Nigeria's critical oil and gas infrastructure security. The article also highlights the growing market for military UAVs and potential benefits for other defense primes like Boeing, Lockheed Martin, and Northrop Grumman.

**4. RTX stock sets up Monday: Fed minutes, Taiwan drills and the $185 line**
- Source: ts2.tech | 20251229T065842 | Somewhat-Bearish | Relevance: 62%
- RTX stock closed down on Friday at $185.17, with investors focusing on upcoming Fed minutes, year-end portfolio adjustments, and new geopolitical developments. China's live-fire drills around Taiwan have put defense contractors back in the spotlight, while traders also anticipate U.S. economic data and the potential for a "Santa Claus rally" before year-end. The company is set to report quarterly results on January 27, with the $185 stock price level being a key watch point for traders.

**5. CACI Appoints Michael Gilday and David Keffer to its Board of Directors**
- Source: 01net | 20251230T160826 | Somewhat-Bullish | Relevance: 62%
- CACI International Inc has announced the appointment of Adm. Michael Gilday, U.S. Navy (Ret.), and David Keffer to its Board of Directors, effective January 1, 2026. These appointments follow the passing of Michael A. Daniels and the resignation of William L. Jews. The new independent directors bring extensive experience in the defense sector and financial leadership, aiming to strengthen CACI's ability to deliver solutions and drive shareholder value.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Morgan Stanley | $714 | $720 | -1% |
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Morgan Stanley | main | Overweight |
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.76 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $82.3B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.76 |
| Forward P/E | 19.9 |
| Current P/E | 22.1 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-1.0% over 5 days). Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.12), confirming momentum. RSI neutral at 53. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.31% (CS: 50) | Neutral |
| RSI_14 | 53.2 | Neutral |
| MACD Histogram | 2.12 | Bullish |
| vs SMA20 | 1.016x | Above |
| vs SMA50 | 1.005x | Above |
| vs SMA200 | 1.056x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $574.40
- **Stop Loss:** $554.78 (3.4% risk)
- **Target:** $594.02 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 67
- **Position Value:** $38,484.80
- **Portfolio %:** 38.48%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*